Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Figueras

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
The Annals of Pharmacotherapy|February 11, 2005
Treatment of type 2 diabetes in primary health care: a drug utilization studyDolores Mino-León, Albert Figueras, Dante Amato, et al.
Drug Safety|October 25, 2025
Strengthening Signal Detection in Pharmacovigilance by Using International Nonproprietary Name (INN) StemsRaffaella Balocco, Jeffrey K Aronson, Sarel F Malan, et al.
European Journal of Clinical Pharmacology|March 3, 2017
Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detectionLorraine Plessis, Ainhoa Gómez, Núria García, et al.
Journal of Materials Science. Materials in Medicine|May 8, 2007
Biomolecular papain thin films growth by laser techniquesEnikö György, Jose Santiso, Albert Figueras, et al.
Expert Opinion on Drug Safety|August 18, 2017
Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associationsAdalton Ribeiro, Silvana Lima, Maria-Elisa Zampieri, et al.
BMC Medical Informatics and Decision Making|December 16, 2021
Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in CataloniaM Àngels Pons-Mesquida, Míriam Oms-Arias, Eduard Diogène-Fadini, et al.
Drug Safety|October 30, 2003
Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription padsJosep Maria Castel, Albert Figueras, Consuelo Pedrós, et al.
BMC Medical Informatics and Decision Making|March 20, 2022
Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self AuditM Àngels Pons-Mesquida, Míriam Oms-Arias, Albert Figueras, et al.
European Journal of Clinical Pharmacology|July 2, 2020
Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan AfricaAgnes Elangwe, Jean-Claude Katte, Donald Tchapmi, et al.
European Journal of Clinical Pharmacology|July 25, 2018
Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposesAlfredo J Rodrigues-Neto, Camila Biazoni-Albaricci, Adalton Ribeiro, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
The Annals of Pharmacotherapy|February 11, 2005
Treatment of type 2 diabetes in primary health care: a drug utilization studyDolores Mino-León, Albert Figueras, Dante Amato, et al.
Drug Safety|October 25, 2025
Strengthening Signal Detection in Pharmacovigilance by Using International Nonproprietary Name (INN) StemsRaffaella Balocco, Jeffrey K Aronson, Sarel F Malan, et al.
European Journal of Clinical Pharmacology|March 3, 2017
Lack of essential information in spontaneous reports of adverse drug reactions in Catalonia-a restraint to the potentiality for signal detectionLorraine Plessis, Ainhoa Gómez, Núria García, et al.
Journal of Materials Science. Materials in Medicine|May 8, 2007
Biomolecular papain thin films growth by laser techniquesEnikö György, Jose Santiso, Albert Figueras, et al.
Expert Opinion on Drug Safety|August 18, 2017
Filling quality of the reports of adverse drug reactions received at the Pharmacovigilance Centre of São Paulo (Brazil): missing information hinders the analysis of suspected associationsAdalton Ribeiro, Silvana Lima, Maria-Elisa Zampieri, et al.
BMC Medical Informatics and Decision Making|December 16, 2021
Safer prescription of drugs: impact of the PREFASEG system to aid clinical decision-making in primary care in CataloniaM Àngels Pons-Mesquida, Míriam Oms-Arias, Eduard Diogène-Fadini, et al.
Drug Safety|October 30, 2003
Stimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription padsJosep Maria Castel, Albert Figueras, Consuelo Pedrós, et al.
BMC Medical Informatics and Decision Making|March 20, 2022
Impact of a system to assist in clinical decision-making in primary healthcare in Catalonia: prescription Self AuditM Àngels Pons-Mesquida, Míriam Oms-Arias, Albert Figueras, et al.
European Journal of Clinical Pharmacology|July 2, 2020
Adverse drug reactions to anti-diabetic drugs are commonest in patients whose treatment do not adhere to diabetes management clinical guidelines: cross-sectional study in a tertiary care service in sub-Saharan AfricaAgnes Elangwe, Jean-Claude Katte, Donald Tchapmi, et al.
European Journal of Clinical Pharmacology|July 25, 2018
Towards preventive pharmacovigilance through medicine misuse identification: an example with recombinant human growth hormone for aesthetic purposesAlfredo J Rodrigues-Neto, Camila Biazoni-Albaricci, Adalton Ribeiro, et al.
Pageof 7